A Randomized Controlled Trial of the Treatment of Mallet Fractures

August 17, 2012 updated by: Dr. D.B. Wouters, Conmed Linvatec Benelux

A Randomized Controlled Trial of the Treatment of Mallet Fractures: Conservative Versus Operative Using One Meniscus Arrow®

Intra-articular fractures at the dorsal base of the distal phalanx of the hand are usually referred to as Mallet fractures. Treatment of Mallet fractures remains controversial. Although no differences in clinical results are reported between conservative treatment and operative treatment, operative treatment is suggested for fractures involving more than 30% of articular surface. There are many different operative techniques, all with specific disadvantages. The investigators hypothesis is that operative treatment of Mallet fractures with one Meniscus Arrow® has a better outcome than conservative treatment with a Mallet splint.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

84

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: D Wouters, MD, PhD
  • Phone Number: +31-134655655
  • Email: dwouters@tsz.nl

Study Contact Backup

Study Locations

      • Nijmegen, Netherlands, 6532SZ
        • Not yet recruiting
        • Canisius-Wilhelmina Hospital
        • Contact:
          • W vd Stappen, MD
    • Noord-Barbant
      • Tilburg, Noord-Barbant, Netherlands, 5022GC
        • Recruiting
        • St. Elisabeth Hospital
        • Contact:
          • M. Verhofstad, MD,PhD
        • Principal Investigator:
          • M Verhofstad, MD, PhD
    • Noord-Brabant
      • Breda, Noord-Brabant, Netherlands, 4818CK
        • Not yet recruiting
        • Amphia Hospital
        • Contact:
          • D de Vos, MD, PhD
      • Eindhoven, Noord-Brabant, Netherlands, 5623EJ
        • Not yet recruiting
        • Catharaina Hospital
        • Contact:
          • A vdVeen, Md, PhD
      • Tilburg, Noord-Brabant, Netherlands, 5042AD
        • Recruiting
        • Twee Steden Hospital
        • Principal Investigator:
          • Fenne Aarts, MD
    • Noord-Holland
      • Haarlem, Noord-Holland, Netherlands, 2035RC
        • Not yet recruiting
        • Kennemer Gasthuis Hospital
        • Contact:
          • M Heetveld, Md, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • avulsion fracture involving more than 30% of articular surface

Exclusion Criteria:

  • (sub)luxation of the distal phalanx
  • patients with a Mallet fracture developed 3 weeks or more prior to presentation
  • patients with a Mallet fracture with failure of conservative treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Operative
operative treatment of a Mallet fracture with a biodegradable Meniscus Arrow®
Closed reduction of the Mallet fracture and fixation with 1 biodegradable meniscus Arrow®
Active Comparator: Conservative
Conservative treatment of a Mallet fracture with a Mallet splint
Conservative treatment of the Mallet fracture with the traditional Mallet splint.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Extension deficit
Time Frame: 1 year
To evaluate the extension deficit after conservative and operative treatment of a Mallet fracture using the Crawford criteria.
1 year
extension deficit
Time Frame: 1 year
at every visit, the extension in the DIP joint, is measured
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
wound healing disturbances
Time Frame: 1 year
at every control, this is noted
1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
nail deformaties
Time Frame: 1 year
at every control nail deformaties, if present, are noted
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2011

Primary Completion (Anticipated)

January 1, 2014

Study Registration Dates

First Submitted

October 31, 2010

First Submitted That Met QC Criteria

November 1, 2010

First Posted (Estimate)

November 2, 2010

Study Record Updates

Last Update Posted (Estimate)

August 20, 2012

Last Update Submitted That Met QC Criteria

August 17, 2012

Last Verified

August 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Mallet2010

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mallet Fracture

Clinical Trials on Biodegradable Meniscus Arrow®

3
Subscribe